LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

Home・Aktien・Cellectar Biosciences Inc

Search

C
Cellectar Biosciences Inc

Geschlossen

2.23 -3.88

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

2.23

Max

2.37

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+337.71% upside

Cellectar Biosciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

10. Juni 2026, 23:36 UTC

Ergebnisse

Correction to Oracle Reports Higher 4Q Profit Article

10. Juni 2026, 23:19 UTC

Heiße Aktien

Stocks to Watch: Oracle, Oxford Industries, Humacyte, PureCycle Technologies

10. Juni 2026, 23:09 UTC

Wichtige Markttreiber

PureCycle Technologies Slides on Offerings of Stock and Convertible Notes

10. Juni 2026, 23:04 UTC

Ergebnisse

Oracle Reports Higher 4Q Profit on Surging Cloud Revenue -- Update

10. Juni 2026, 20:44 UTC

Wichtige Markttreiber

Caterpillar Raises Quarterly Dividend 8%

10. Juni 2026, 23:49 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott: Northern Star Should Take No Options Off The Table

10. Juni 2026, 23:48 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott: Reiterates Call For Formal Strategic Review of Northern Star

10. Juni 2026, 23:48 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott: Northern Star Board Must Be Substantially Strengthened Beyond 1 Additional Director

10. Juni 2026, 23:47 UTC

Market Talk

Nintendo's Stock Recovery Likely Deferred Without Mario Game -- Market Talk

10. Juni 2026, 23:47 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott: Board Letter Indicates It Doesn't Understand Magnitude of Change Required

10. Juni 2026, 23:46 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott Investment Management: Northern Star Letter Validates Investment Thesis

10. Juni 2026, 23:38 UTC

Market Talk

Global Equities Roundup: Market Talk

10. Juni 2026, 23:38 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10. Juni 2026, 23:38 UTC

Market Talk

Nikkei Likely to Fall on Renewed Concerns About Iran Conflict -- Market Talk

10. Juni 2026, 23:32 UTC

Market Talk

Oil Rises Amid Escalating Supply-Disruption Fears -- Market Talk

10. Juni 2026, 23:20 UTC

Market Talk

Wesfarmers's Bunnings Business Looks Resilient to Macro Headwinds -- Market Talk

10. Juni 2026, 22:05 UTC

Market Talk

Correction to Bank of Canada Stays on Hold Market Talk

10. Juni 2026, 21:57 UTC

Ergebnisse

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10. Juni 2026, 21:52 UTC

Ergebnisse

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10. Juni 2026, 21:35 UTC

Ergebnisse

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10. Juni 2026, 21:22 UTC

Ergebnisse

Oracle Stock Slides on Increased Capital Spending -- WSJ

10. Juni 2026, 20:50 UTC

Market Talk

Ergebnisse

Tech, Media & Telecom Roundup: Market Talk

10. Juni 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

10. Juni 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10. Juni 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10. Juni 2026, 20:39 UTC

Market Talk

Ergebnisse

Oracle Needs to Raise Less Capital to Fund Data-Center Buildout -- Market Talk

10. Juni 2026, 20:34 UTC

Ergebnisse

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10. Juni 2026, 20:33 UTC

Ergebnisse

This 'Amazon for Travel' Firm Beat Earnings Expectations. The Stock Is Soaring. -- Barrons.com

10. Juni 2026, 20:33 UTC

Market Talk

Ergebnisse

Global Equities Roundup: Market Talk

10. Juni 2026, 20:33 UTC

Market Talk

Ergebnisse

Oracle Health Expected to Grow Double-Digits This Fiscal Year -- Market Talk

Peer-Vergleich

Kursveränderung

Cellectar Biosciences Inc Prognose

Kursziel

By TipRanks

337.71% Vorteil

12-Monats-Prognose

Durchschnitt 10.33 USD 337.71%

Hoch 11 USD

Tief 10 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Cellectar Biosciences Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

3 ratings

3

Buy

0

Halten

0

Sell

Basierend auf 3 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Cellectar Biosciences Inc – Dist abgegeben haben.

Finanzen

$

Andere Aktien aus dem Sektor

LLY

Eli Lilly and Co.

1,136.41

JNJ

Johnson and Johnson

238.85

ABBV

AbbVie Inc

225.29

UNH

UnitedHealth Group Inc

407.06

MRK

Merck & Co Inc.

119

Live chat